Latest Breaking News On - Hanmi pharmaceutical - Page 16 : comparemela.com

Spectrum Pharmaceuticals, Inc : Spectrum Pharmaceuticals Announces Data from Poster Presentation for Poziotinib in NSCLC Patients with G778_P780dup HER2 Exon 20 Mutations at ESMO Congress 2022

Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced data from a poster presentation titled: High Activity of

United statesFrance generalFrancois lebelRobert uhlXiuning leExchange commissionSpectrum pharmaceuticals incEuropean society for medical oncology congressSpectrum pharmaceuticalsPatient groupHigh activityNon small cell lung cancerAssistant professorCancer centerEuropean societyMedical oncology congress

Spectrum Pharmaceuticals Announces Poster Presentation for Poziotinib in NSCLC Patients with G778_P7

BOSTON (BUSINESS WIRE) Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced a poster presentation titled: High Activity of Poziotinib in G778 P780dup HER2 Exon 20 Insertion Mutations in Non-Small Lung Cancer (NSCLC). The poster wil.

United statesFrance generalRobert uhlXiuning leDivision of internal medicineEuropean society for medical oncology congressUniversity of texas md anderson cancer centerSpectrum pharmaceuticalsExchange commissionSpectrum pharmaceuticals nasdaqSpectrum pharmaceuticals incDepartment of thoracic headHigh activityNon small lung cancerEuropean societyMedical oncology congress

Standigm names Carl Foster chief business officer to expand strategic partnerships for AI drug discovery

/PRNewswire/ Standigm Inc. ("Standigm"), the leading workflow artificial intelligence (AI) drug discovery company, today announced the appointment of Chief.

Soult ukpyolsiSouth koreaUnited kingdomOxford glycosciencesCarl fosterJinhan kimUniversity of kansasPraecis pharmaceuticalsStandigm incKing pharmaceuticalsMerck kgaMerck kgaaMilner therapeutics instituteCempra pharmaceuticalsCo incChief business officer carl

Nucleic Acid Therapeutics CDMO Market worth $4 69 Bn by 2030 - Exclusive Report by InsightAce Analytic

/PRNewswire/ InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on "Global Nucleic Acid Therapeutics CDMO Market By Technology.

United statesSouth africaNew zealandSouth koreaOmnichemnv omnichemBiospring gmbLaboratorios farmacAsia pacificAgilent technologieArranta bioArranta bio recipharmAgilent technologies incCorden pharma internationalMarket by technology columnAjinomoto coLaboratories co ltd

KT Corporation and Hanmi Pharmaceutical promote business cooperation with Digital Pharm, a Korean company specializing in digital treatment devices and electronic drugs

KT Corporation and Hanmi Pharmaceutical promote business cooperation with Digital Pharm, a Korean company specializing in digital treatment devices and electronic drugs
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Soult ukpyolsiSouth koreaJay ryuKoo hyun moKim dai jinTelecommunications businessDrug administrationCheckmate capital groupCatholic university of korea technology holding companyDigital healthKt corporationCatholic universityCatholic university seoul stWall streetHanmi pharmaceuticalDigital pharm